Evaluation of the Hepatoprotective Activity of Silymarin Against Acetaminophen-Induced Oxidative Hepatic Injury in Wistar Rats
Journal of Pharma Insights and Research · 05.04.2026 · 4 (2) · 142-150
DOI: 10.69613/mmkqdt03 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharma Insights and Research, online erschienen am 05.04.2026. Verfasst von Supriya V und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The liver serves as the central hub for the metabolic transformation and detoxification of diverse xenobiotics, rendering it inherently susceptible to chemical-induced pathologies. Acetaminophen (paracetamol) represents a widely utilized analgesic and antipyretic agent that, while safe at therapeutic concentrations, precipitates acute hepatotoxicity when administered at supratherapeutic levels. This injury originates from the metabolic conversion of acetaminophen into N-acetyl-p-benzoquinone imine (NAPQI), a reactive intermediate that depletes hepatic glutathione reservoirs, triggers oxidative stress, and induces hepatocellular necrosis. While N-acetylcysteine remains the primary clinical intervention, its efficacy is often limited by a narrow therapeutic window and potential adverse reactions. Consequently, the search for phytotherapeutic alternatives has identified silymarin, a flavonolignan complex derived from Silybum marianum, as a potent hepatoprotective candidate. Experimental evaluation in male Wistar rats shows that silymarin significantly mitigates hepatic damage induced by acute acetaminophen exposure. Administration of silymarin at doses of 100 mg/kg and 200 mg/kg results in a marked reduction of serum biomarkers, including alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase, while simultaneously restoring endogeneous antioxidant levels. Histopathological analysis corroborates these biochemical findings, revealing a preservation of hepatic architecture and a reduction in centrilobular necrosis. These observations indicate that silymarin exerts its protective effects through robust free-radical scavenging, membrane stabilization, and the stimulation of hepatocyte regeneration. The findings provide substantial evidence for the integration of silymarin as a natural therapeutic strategy for managing drug-induced liver injury
Zitieren
APA
V, S., A, K. D., G, N. D., M, H., & S, N. R. (2026). Evaluation of the Hepatoprotective Activity of Silymarin Against Acetaminophen-Induced Oxidative Hepatic Injury in Wistar Rats. Journal of Pharma Insights and Research, 4(2), 142-150. https://doi.org/10.69613/mmkqdt03
Vancouver
V S, A KD, G ND, M H, S NR. Evaluation of the Hepatoprotective Activity of Silymarin Against Acetaminophen-Induced Oxidative Hepatic Injury in Wistar Rats. Journal of Pharma Insights and Research. 2026;4(2):142-150. doi:10.69613/mmkqdt03
BibTeX
@article{V2026,
author = {V, Supriya and A, Kamakshi Devi and G, Naga Deepika and M, Harshitha and S, Nageswara Rao},
title = {Evaluation of the Hepatoprotective Activity of Silymarin Against Acetaminophen-Induced Oxidative Hepatic Injury in Wistar Rats},
journal = {Journal of Pharma Insights and Research},
year = {2026},
volume = {4},
number = {2},
pages = {142--150},
doi = {10.69613/mmkqdt03}
}
EUVIMED